Though only about 3% of adults with employer coverage had a prescription in 2022, demand for and spending on GLP-1 drugs has grown and could continue to grow
Formulated with selenium to aid detoxification and support energy production
Looking ahead, employers may continue to face the competing pressures of employee demand for GLP-1 drugs and concerns about costs
The core difference between them comes down to how many metabolic pathways they target: Zepbound is a dual hormone agonist, while Retatrutide is a triple hormone agonist (often nicknamed the triple G)
Consistency is key to stable results, so setting a calendar reminder helps maintain your weekly rhythm with PlexusDx treatment
Common Mild Side Effects Short-term redness or slight irritation at the injection site Light water retention, especially during the initial weeks Increased appetite Mild headaches (rare and usually transient) Temporary fatigue or lightheadedness immediately after injection Who Should Avoid This Therapy People with an active cancer diagnosis or history of cancer, as GH secretagogues increase cellular replication rates Pregnant or breastfeeding individuals should avoid this therapy due to insufficient safety data on its effects during these stages
